Pancreatic Cancer Research

ResearcherKaohsiung Medical UniversityActive in the last 2 years

Tze‐Sing Huang

Matched on ORCID iD 0000-0001-8736-4330; OpenAlex author ID A5031677254. Sources: OpenAlex.

Their work

Papers
7 (first author 0, last author 4)
Trials
0
Grants
0
Labs led
1
Collaborators
12
Papers, trials and grants by year

2018: 1 paper · 2019: 2 papers · 2020: none · 2021: none · 2022: none · 2023: 1 paper · 2024: 2 papers · 2025: 1 paper

Papers 7

  1. Author Correction: Crosstalk between FTH1 and PYCR1 dysregulates proline metabolism and mediates cell growth in KRAS-mutant pancreatic cancer cells Co-author DOI 10.1038/s12276-025-01437-w↗
  2. Crosstalk between FTH1 and PYCR1 dysregulates proline metabolism and mediates cell growth in KRAS-mutant pancreatic cancer cells. Co-author DOI 10.1038/s12276-024-01300-4↗
  3. Development of a Humanized Antibody Targeting Extracellular HSP90α to Suppress Endothelial-Mesenchymal Transition-Enhanced Tumor Growth of Pancreatic Adenocarc… Last author DOI 10.3390/cells13131146↗
  4. Krüppel-like factor 10 modulates stem cell phenotypes of pancreatic adenocarcinoma by transcriptionally regulating notch receptors. Co-author DOI 10.1186/s12929-023-00937-z↗
  5. Endothelial-mesenchymal transition harnesses HSP90α-secreting M2-macrophages to exacerbate pancreatic ductal adenocarcinoma. Last author DOI 10.1186/s13045-019-0826-2↗
  6. Octyl Gallate Induces Pancreatic Ductal Adenocarcinoma Cell Apoptosis and Suppresses Endothelial-Mesenchymal Transition-Promoted M2-Macrophages, HSP90α Secreti… Last author DOI 10.3390/cells9010091↗
  7. Myeloid-derived macrophages and secreted HSP90α induce pancreatic ductal adenocarcinoma development. Last author DOI 10.1080/2162402x.2018.1424612↗

Closest collaborators

The 12 strongest of 12 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Chi-Shuan Fan · 6 shared papers, 2018–2025 · strength 0.88
  2. Kee Voon Chua · 4 shared papers, 2018–2024 · strength 0.49
  3. Yen‐Hao Su · 2 shared papers, 2024–2025 · strength 0.39
  4. Ji Min Park · 2 shared papers, 2024–2025 · strength 0.39
  5. Wun‐Shaing Wayne Chang · 2 shared papers, 2024–2025 · strength 0.39
  6. Shih‐Yi Huang · 2 shared papers, 2024–2025 · strength 0.39
  7. Ching‐Feng Chiu · 2 shared papers, 2024–2025 · strength 0.39
  8. Chia‐Chi Chen · 3 shared papers, 2018–2019 · strength 0.30
  9. Yi‐Chih Tsai · 1 shared paper, 2023 · strength 0.19
  10. Hui-Ju Ch’ang · 1 shared paper, 2023 · strength 0.19
  11. Chung‐Pin Li · 2 shared papers, 2018–2019 · strength 0.18
  12. Li‐Tzong Chen · 1 shared paper, 2018 · strength 0.08

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.